medline.ch Onkologie

	Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway. Clin Exp Med Stensland M, Bru KF, Austdal M, Dahl IH, Jonsdottir K, Lende TH, Heimvik C, Elve I, Omdal R, van der Giezen M, Kvivik I, Tangeland B, Davidsen L, Hashemi M, Cais A, van Dijk KJ, Seyoum Y, Blåfjelldal V, Sola ST, Papadopoulos A, Kiriakidou N, Ioakeimidis I, Diou C, Sarafis I, Delopoulos A, Janssen EAM, Gilje B, Tjensvoll K. PMID: 41655181 [PubMed - as supplied by publisher]
	"Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy". Clin Exp Med Aghaei M, Bahreiny SS, Mahdizade AH, Abbasi A, Magharati A, Yousefi-Avarvand A. PMID: 41655180 [PubMed - as supplied by publisher]
	Polycystic ovary syndrome (PCOS) affects relative embryo morphokinetics observed by time-lapse imaging: an observational study. Arch Gynecol Obstet Garçon VM, Dietrich JE, Strowitzki T, Freis A. PMID: 41655163 [PubMed - indexed for MEDLINE]
	cGAS-STING Pathway in Gastrointestinal Malignancies: Mechanistic Insights and Translational Therapeutic Opportunities. J Gastrointest Cancer Rathod H, Jain P, Dharme KK, Ajazuddin. PMID: 41655160 [PubMed - indexed for MEDLINE]
	An autopsy case of multiple liver metastases from minute pancreatic acinar cell carcinoma clinically diagnosed as primary hepatic acinar cell carcinoma. Clin J Gastroenterol Okujima Y, Tada F, Murakami H, Miyaoka H, Kurata M, Masumoto J. PMID: 41655158 [PubMed - as supplied by publisher]
	Liver Steatosis-Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication. Aliment Pharmacol Ther Lin YS, Lin YC, Chen YY, Chen YM, Chen IC, Tsai HJ, Chen CC, Lee SW, Yang HI, Lee TY. PMID: 41655131 [PubMed - as supplied by publisher]
	Nab-paclitaxel for the treatment of cervical cancer: a systematic review of clinical safety and effectiveness. J Chemother Wiwekananda IGNA, Malek NANN, Endharti AT, Permatasari HK. PMID: 41655064 [PubMed - as supplied by publisher]
	RETRACTION: Epigallocatechin Gallate in Combination With Eugenol or Amarogentin Shows Synergistic Chemotherapeutic Potential in Cervical Cancer Cell Line. J Cell Physiol PMID: 41655042 [PubMed - in process]
	RETRACTION: Long Noncoding RNA lnc-ABCA12-3 Promotes Cell Migration, Invasion, and Proliferation by Regulating Fibronectin 1 in Esophageal Squamous Cell Carcinoma. J Cell Biochem PMID: 41655036 [PubMed - in process]
	Cutaneous Squamous Cell Carcinoma Arising in Lupus Vulgaris: A Systematic Review. J Cutan Med Surg Lazarowitz R, Creighton R, Aluko E, Garuba E, Barnawi G, Jeremian R, Julanon N, Dumont S, Piguet V. PMID: 41655009 [PubMed - as supplied by publisher]
	Schwannomatosis tumor modeling: progress and prospects for translational research. J Biol Eng Madison MS, Xu H, Gonzalez-Vargas Y, Yonk MG, Thompson CM, Haney H, Babbitt D, Du Y, Hirbe AC, Boulis NM, Bai RY, Lei K. PMID: 41654957 [PubMed - as supplied by publisher]
	Rewiring tumor cytokine networks to enhance immune checkpoint blockade: mechanisms, engineering, and clinical translation. J Exp Clin Cancer Res Wang X, Wang J, Wang Q, Ding G, Huang Y, Feng Y. PMID: 41654940 [PubMed - as supplied by publisher]
	Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India. J Ovarian Res Yeshala SK, Panda SS, Moharana L, Saju SV, Rathinam K, Raju SH, Sehrawat A, Sundriyal D, Phillip AO, Kinsely PA, Bhatia KP, Kayal S, Dubashi B, Cyriac SL, Natarajan S, Samantaray L, Mohanty SS, Sadangi S, Pradhan S, Rana A, Ganesan P. PMID: 41654913 [PubMed - as supplied by publisher]
	Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer. Cell Commun Signal Luo X, Cui J, Shi J, Sun G, Zhang L, Li Y, Guo Y, Kuai L, Sun T, Luo Q, Cai J, An Q, Zhang W, Xiao F, Zhao G. PMID: 41654905 [PubMed - as supplied by publisher]
	Potential correlation between high SNHG expression and poor pancreatic cancer prognosis: evidence from systematic reviews and meta-analyses. Cancer Cell Int Du SQ, Liu YT, Yang F, Zhang J. PMID: 41654901 [PubMed - as supplied by publisher]
	Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives. Eur J Med Res El-Khawaga AM, Youssef OI, El-Dydamoni OA, Ragab WM, Mohammed RAE. PMID: 41654877 [PubMed - as supplied by publisher]
	Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response. Exp Hematol Oncol Qiao K, Wu L, Yang L, Liu M, Jiang C, Chen Y, Zhang Z, Yu J, Wei D, Xu Y. PMID: 41654863 [PubMed - as supplied by publisher]
	Comparison of timing for early postoperative intake in patients with upper gastrointestinal cancer: a network meta-analysis. BMC Surg Yang Z, Fan Y, Wei J, Nan L, Li Q. PMID: 41654844 [PubMed - as supplied by publisher]
	Neutrophils in nasopharyngeal carcinoma: from mechanisms to therapeutics. J Transl Med Liu W, You B, Miao Z, Yu J, Ding X, Zhou C. PMID: 41654839 [PubMed - as supplied by publisher]
	Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives. J Nanobiotechnology Zhang B, Iqbal MS, Yan Y, Wang H, Wang X, Zhang Y, Guo B. PMID: 41654811 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1907827

Seite 1 von 95392

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung